Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Clinical trial NCT06408259 · RECRUITING
Trial details
- NCT number
- NCT06408259
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-08
- Primary completion
- 2031-04-11
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.